Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Sharad Rajpal

Neurological Surgery Boulder, CO Medical Doctor

NPI 1699730986 CMS profile 31544

4743 Arapahoe Ave Ste 202, Ste 350, Boulder, CO 80303

Open in the dashboard

General payments

$2,803,927

1,856 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$2,100

1 holding reported · through program year 2025

Research they led as principal investigator

$34,500 paid to institutions, not to them · program years 2022–2023

Through program year 2025, Sharad Rajpal of Boulder, CO is reported in the CMS Open Payments database as having received $2,803,927 across 1,856 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $34,500 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $2,100 across 1 holding.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $736,635 370
2024 General $625,946 277
2023 General $481,802 297
2022 General $365,173 274
2021 General $298,011 282
2020 General $148,992 161
2019 General $147,368 195
2025 Ownership $2,100 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Sharad Rajpal
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Sharad Rajpal were reported at $736,635. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Sharad Rajpal Neurological Surgery median Middle half National median
2019 $147,368 $582 $138–$3,006 $163
2020 $148,992 $294 $76–$2,174 $114
2021 $298,011 $387 $105–$2,432 $132
2022 $365,173 $542 $139–$2,989 $149
2023 $481,802 $534 $145–$2,697 $160
2024 $625,946 $574 $155–$3,046 $164
2025 $736,635 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $1,155,211 1,217 payments
  2. SI-BONE, Inc. $1,131,708 77 payments
  3. Medtronic USA, Inc. $227,897 264 payments
  4. Cerapedics, Inc. $214,506 164 payments
  5. Zimmer Biomet Holdings, Inc. $62,034 93 payments
  6. Clariance SAS $3,647 4 payments
  7. Alphatec Spine, Inc $2,576 9 payments
  8. Exapnding Innovations, Inc. $2,235 3 payments
  9. Globus Medical, Inc. $1,770 5 payments
  10. Integrity Implants Inc $1,456 7 payments
  11. Other $887 13 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $1,069,737 17 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $989,552 175 payments
  3. Consulting Fee $547,360 222 payments
  4. Travel and Lodging $151,732 648 payments
  5. Food and Beverage $44,421 791 payments
  6. Education $1,081 2 payments
  7. Gift $44 1 payment
Products named General payments · program years 2019–2025
  1. IFUSE IMPLANT SYSTEM sacroiliac joint dysfunction $728,812 26 payments
  2. MAZOR X SYSTEM $484,010 513 payments
  3. IFUSE IMPLANT SYSTEM sacroiliac joint dysfunction $235,762 5 payments
  4. I-FACTOR PEPTIDE ENHANCED BONE GRAFT $214,416 163 payments
  5. IFUSE IMPLANT $165,879 37 payments
  6. O-ARM-ST $109,721 79 payments
  7. UNID_PASS $92,574 121 payments
  8. Mazor X Stealth Edition $68,160 105 payments
  9. STEALTHSTATION S8 PLATFORM $58,092 54 payments
  10. O-ARM $56,407 48 payments
  11. Other $289,359 429 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 52 billing codes

Paid by Medicare

$214,481

Medicare's payments for the services billed

Medicare patients

306

Average age 74

Services billed

771

178 women, 128 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 58%
Osteoporosis 33%
Ischemic heart disease 30%
Depression 25%
Diabetes 18%
Chronic kidney disease 15%
Cancer 15%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

1,856 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in Colorado

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record